131 related articles for article (PubMed ID: 19892025)
1. The additional use of viral entry inhibitors during autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma and HIV-1 infection.
Hütter G; Allers K; Schneider T
Biol Blood Marrow Transplant; 2011 Apr; 17(4):586-7. PubMed ID: 19892025
[No Abstract] [Full Text] [Related]
2. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
3. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
Pippi F
Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
[TBL] [Abstract][Full Text] [Related]
4. HIV-associated non-Hodgkin lymphoma: viral origins and therapeutic options.
Krishnan A; Zaia JA
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):584-9. PubMed ID: 25696915
[TBL] [Abstract][Full Text] [Related]
5. Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: complications and outcome.
Kumar L; Ganessan P; Ghosh I; Panda D; Gogia A; Mandhania S
Natl Med J India; 2010; 23(6):330-5. PubMed ID: 21561042
[TBL] [Abstract][Full Text] [Related]
6. The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.
Villanueva ML; Vose JM
Clin Adv Hematol Oncol; 2006 Jul; 4(7):521-30. PubMed ID: 17147239
[TBL] [Abstract][Full Text] [Related]
7. Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.
Phillips GL; Meisenberg BR; Reece DE; Adams VR; Badros AZ; Brunner JL; Fenton RG; Filicko J; Grosso DL; Hale GA; Howard DS; Johnson VP; Kniska A; Marshall KW; Mookerjee B; Nath R; Rapoport AP; Sarkodee-Adoo C; Takebe N; Vesole DH; Wagner JL; Flomenberg N
Bone Marrow Transplant; 2004 Apr; 33(8):781-7. PubMed ID: 14767498
[TBL] [Abstract][Full Text] [Related]
8. Autologous stem cell transplantation for malignant lymphomas.
Reményi P; Masszi T; Kriván G; Goda V; Réti M
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S104-6. PubMed ID: 9916651
[TBL] [Abstract][Full Text] [Related]
9. [Successful treatment with foscarnet for disseminated varicella-zoster infection after reduced intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma].
Aoyama Y; Yamamura R; Shima E; Nakamae H; Makita K; Hasegawa T; Sakamoto C; Terada Y; Kho G; Ohta K; Yamane T; Takubo T; Hino M
Rinsho Ketsueki; 2003 Jul; 44(7):451-5. PubMed ID: 12931563
[TBL] [Abstract][Full Text] [Related]
10. Advances in the management of HIV-related non-Hodgkin lymphoma.
Behler CM; Kaplan LD
Curr Opin Oncol; 2006 Sep; 18(5):437-43. PubMed ID: 16894290
[TBL] [Abstract][Full Text] [Related]
11. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
[TBL] [Abstract][Full Text] [Related]
12. High-dose therapy and autologous stem cell transplantation for children with HIV-associated non-Hodgkin lymphoma.
Fluri S; Ammann R; Lüthy AR; Hirt A; Aebi C; Duppenthaler A; Leibundgut K
Pediatr Blood Cancer; 2007 Dec; 49(7):984-7. PubMed ID: 16685736
[TBL] [Abstract][Full Text] [Related]
13. Nonmyeloablative stem cell transplantation following a cytoreductive autograft in patients with non-Hodgkin's lymphoma who relapse after autologous transplantation.
Yang DH; Lee JJ; Kim YK; Cho SH; Chung IJ; Kim HJ
Bone Marrow Transplant; 2004 Nov; 34(10):915-6. PubMed ID: 15517010
[No Abstract] [Full Text] [Related]
14. Adopting autologous hematopoietic stem cells with non-functional CCR5 and CXCR4 against HIV.
Lai Y
Bone Marrow Transplant; 2010 Apr; 45(4):770-1. PubMed ID: 19718064
[No Abstract] [Full Text] [Related]
15. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
Laudi N; Arora M; Burns LJ; Miller JS; McGlave PB; Barker JN; Ramsay NK; Orchard PJ; Macmillan ML; Weisdorf DJ
Biol Blood Marrow Transplant; 2005 Feb; 11(2):129-35. PubMed ID: 15682074
[TBL] [Abstract][Full Text] [Related]
16. Role of hematopoietic stem cell transplantation in the treatment of non-Hodgkin's lymphoma.
Bierman PJ; Phillips GL
Cancer Treat Res; 2009; 144():357-97. PubMed ID: 19779882
[No Abstract] [Full Text] [Related]
17. Autologous stem cell infusion for acute myeloblastic leukemia in an HIV-1 carrier.
Schneider E; Lambermont M; Van Vooren JP; Bastin G; Feremans W; Kentos A; Lemoine F; Liesnard C; Delforge ML; Crenier L; Capel P; Farber CM
Bone Marrow Transplant; 1997 Oct; 20(7):611-2. PubMed ID: 9337065
[TBL] [Abstract][Full Text] [Related]
18. Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.
Messina G; Quartarone E; Console G; Cuzzola M; Iacopino O; Martino M; Irrera G; Morabito F; Iacopino P
Haematologica; 2002 Jul; 87(7):ECR22. PubMed ID: 12091138
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
[TBL] [Abstract][Full Text] [Related]
20. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Endo T; Sakai T; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T; Sawada K
Bone Marrow Transplant; 2001 Feb; 27(4):433-6. PubMed ID: 11313673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
